11455859

Source:http://linkedlifedata.com/resource/pubmed/id/11455859

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004364, umls-concept:C0087111, umls-concept:C0205195, umls-concept:C0220905, umls-concept:C1547011, umls-concept:C1879746
pubmed:issue	1-2
pubmed:dateCreated	2001-7-17
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7910384
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:issn	0344-4325
pubmed:author	pubmed-author:KurkiPP
pubmed:issnType	Print
pubmed:volume	23
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	35-41
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:11455859-Arthritis, Rheumatoid, pubmed-meshheading:11455859-Autoimmune Diseases, pubmed-meshheading:11455859-Clinical Trials as Topic, pubmed-meshheading:11455859-Drug Therapy, Combination, pubmed-meshheading:11455859-Humans, pubmed-meshheading:11455859-Practice Guidelines as Topic, pubmed-meshheading:11455859-Research Design
pubmed:year	2001
pubmed:articleTitle	Regulatory aspects of evaluating combination treatments in autoimmune diseases.
pubmed:affiliation	Department of Pharmacology, National Agency for Medicines, Mannerheimintie 166, P.O. Box 55, FI-00301, Helsinki, Finland. Pekka.Kurki@nam.fi
pubmed:publicationType	Journal Article, Review